Added to YB: 2019-03-15
Pitch date: 2019-03-15
CHRS [bullish]
Coherus Oncology, Inc.
-92.57%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Coherus Oncology, Inc., a biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States.
Market Cap
$205.5M
Pitch Price
$14.41
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.04
P/E
-1.09
EV/Sales
3.03
Sector
Biotechnology
Category
N/A
Show full summary:
COHERUS BIOSCIENCES INC CHRS
A summary for this pitch has not been created yet.
Read full article (0 min)